Dr. Manu Kohli is a principal scientific advisor with significant biotechnology/pharmaceutical experience and expertise in target identification, validation, and early drug discovery. He has led senior scientific research teams in the biotech/pharma sector to advance drugs for a variety of disease indications, with a focus on oncology and infectious diseases. Manu has previously headed research programs in small molecule discovery, immunotherapy, and biologics discovery/development.
Manu has a PhD in biochemistry/molecular biology from Georgetown University and conducted post-doctoral training at Johns Hopkins University. Most recently, He was the Scientific Program Manager in Experimental Therapeutics at the National Cancer Institute (NCI). He has published many research articles in top-tier scientific journals and holds six patents.